Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
896
archived clinical trials in
Gastroesophageal Reflux Disease

A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Phoenix, AZ
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Miami Lakes, FL
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Boston, MA
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Fargo, ND
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Fargo, ND
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Lynchburg, VA
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
(410) 601-8256
mi
from
Egg Harbor City, NJ
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
(410) 601-8256
mi
from
Egg Harbor City, NJ
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Sandy City, UT
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Sandy City, UT
Click here to add this to my saved trials
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated:  9/25/2017
IW-3718 Investigator
mi
from
Christiansburg, VA
A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors
Status: Enrolling
Updated: 9/25/2017
IW-3718 Investigator
mi
from
Christiansburg, VA
Click here to add this to my saved trials
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
In Infants With Symptoms of Tracheomalacia or Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms? A Randomized, Controlled Trial
Status: Enrolling
Updated:  11/15/2017
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
In Infants With Symptoms of Tracheomalacia or Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms? A Randomized, Controlled Trial
Status: Enrolling
Updated: 11/15/2017
Lucile Packard Children's Hospital at Stanford
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Histology Post-Endoscopic Eradication Therapy (EET)
Optimizing Patient Outcomes Through Early Detection of Uncontrolled Acid Reflux After Endoscopic Therapy in Barrett's Esophagus
Status: Enrolling
Updated:  12/11/2017
Northwestern University
mi
from
Chicago, IL
Histology Post-Endoscopic Eradication Therapy (EET)
Optimizing Patient Outcomes Through Early Detection of Uncontrolled Acid Reflux After Endoscopic Therapy in Barrett's Esophagus
Status: Enrolling
Updated: 12/11/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-controlled, Double-blind Study.
Status: Enrolling
Updated:  12/12/2017
University of Iowa Department of Otolaryngology
mi
from
Iowa City, IA
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-controlled, Double-blind Study.
Status: Enrolling
Updated: 12/12/2017
University of Iowa Department of Otolaryngology
mi
from
Iowa City, IA
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
SurgOne Foregut Institute
mi
from
Englewood, CO
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
SurgOne Foregut Institute
mi
from
Englewood, CO
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
Lenox Hill Hospital
mi
from
New York, NY
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
Oregon Health and Science University
mi
from
Portland, OR
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
University of Texas at Houston
mi
from
Bellaire, TX
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
University of Texas at Houston
mi
from
Bellaire, TX
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
OC Reflux
mi
from
Huntington Beach, CA
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
OC Reflux
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
GI Solutions
mi
from
Chicago, IL
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
GI Solutions
mi
from
Chicago, IL
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
NorthShore University HealthSystem
mi
from
Evanston, IL
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
Texas Tech University Health Sciences Center
mi
from
El Paso, TX
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
Texas Tech University Health Sciences Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated:  1/8/2018
Reston Hospital Center/ GW University
mi
from
Reston, VA
Registry to Compare Two Surgical Treatments for GERD
Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry
Status: Enrolling
Updated: 1/8/2018
Reston Hospital Center/ GW University
mi
from
Reston, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Suresh Karne
mi
from
Huntsville, AL
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Suresh Karne
mi
from
Huntsville, AL
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
James Thrasher, MD
mi
from
Little Rock, AR
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
James Thrasher, MD
mi
from
Little Rock, AR
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Dennis Riff
mi
from
Anaheim, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Dennis Riff
mi
from
Anaheim, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Peter Winkle
mi
from
Cypress, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Peter Winkle
mi
from
Cypress, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Ramin Farsad
mi
from
Encinitas, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Ramin Farsad
mi
from
Encinitas, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Prahalad Jajodia
mi
from
Fresno, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Prahalad Jajodia
mi
from
Fresno, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Gurmej Dhillon
mi
from
Fresno, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Gurmej Dhillon
mi
from
Fresno, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Steven Duckor
mi
from
Orange, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Steven Duckor
mi
from
Orange, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Theodor Feinstat
mi
from
Roseville, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Theodor Feinstat
mi
from
Roseville, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Scott Levenson, MD
mi
from
San Carlos, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Scott Levenson, MD
mi
from
San Carlos, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Michael Bennett
mi
from
San Diego, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Michael Bennett
mi
from
San Diego, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. William Snape
mi
from
San Francisco, CA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. William Snape
mi
from
San Francisco, CA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Abbass Shafii
mi
from
Colorado Springs, CO
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Abbass Shafii
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Julio Salcedo
mi
from
Washington,
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Julio Salcedo
mi
from
Washington,
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Daniel Maico
mi
from
Gainesville, FL
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Daniel Maico
mi
from
Gainesville, FL
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Simon Behar
mi
from
Hialeah, FL
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Simon Behar
mi
from
Hialeah, FL
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Wayne Schonfeld, MD
mi
from
Hollywood, FL
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Wayne Schonfeld, MD
mi
from
Hollywood, FL
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Stephen Palte
mi
from
Atlanta, GA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Stephen Palte
mi
from
Atlanta, GA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Nathan Segall
mi
from
Atlanta, GA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Nathan Segall
mi
from
Atlanta, GA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Azazuddin Ahmed, MD
mi
from
Oak Brook, IL
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Azazuddin Ahmed, MD
mi
from
Oak Brook, IL
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Brian Covey, MD
mi
from
Dubuque, IA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Brian Covey, MD
mi
from
Dubuque, IA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Richard McCallum
mi
from
Kansas City, KA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Richard McCallum
mi
from
Kansas City, KA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Robert Braun, MD
mi
from
Topeka, KA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Robert Braun, MD
mi
from
Topeka, KA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Carroll Steinfeld, MD
mi
from
Madisonville, KY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Carroll Steinfeld, MD
mi
from
Madisonville, KY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
David Dulitz, MD
mi
from
Metairie, LA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
David Dulitz, MD
mi
from
Metairie, LA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Bal Raj Bhandari
mi
from
Monroe, LA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Bal Raj Bhandari
mi
from
Monroe, LA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Robert Hardi
mi
from
Chevy Chase, MD
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Robert Hardi
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Braden Kuo
mi
from
Boston, MA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Braden Kuo
mi
from
Boston, MA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Robert Lustig
mi
from
Bridgewater, NJ
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Robert Lustig
mi
from
Bridgewater, NJ
Click here to add this to my saved trials